| 000 | 01911 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518054701.0 | ||
| 264 | 0 | _c20200924 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1531-4995 | ||
| 024 | 7 |
_a10.1002/lary.28236 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLehman, Christine E | |
| 245 | 0 | 0 |
_aAntitumor effect of insulin-like growth factor-1 receptor inhibition in head and neck squamous cell carcinoma. _h[electronic resource] |
| 260 |
_bThe Laryngoscope _c06 2020 |
||
| 300 |
_a1470-1478 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMouth Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPyrazines _xpharmacology |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 |
_aSquamous Cell Carcinoma of Head and Neck _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriazines _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aKhalil, Ashraf A | |
| 700 | 1 | _aAxelrod, Mark J | |
| 700 | 1 | _aDougherty, Michael I | |
| 700 | 1 | _aSchoeff, Stephen S | |
| 700 | 1 | _aTaniguchi, Linnea E | |
| 700 | 1 | _aMendez, Rolando E | |
| 700 | 1 | _aDavid, Abel P | |
| 700 | 1 | _aMcGarey, Patrick O | |
| 700 | 1 | _aHubbard, Matthew A | |
| 700 | 1 | _aDonaldson, Lane | |
| 700 | 1 | _aFrierson, Henry F | |
| 700 | 1 | _aStelow, Edward B | |
| 700 | 1 | _aBekiranov, Stefan | |
| 700 | 1 | _aWulfkuhle, Julia D | |
| 700 | 1 | _aPetricoin, Emanuel F | |
| 700 | 1 | _aGioeli, Daniel G | |
| 700 | 1 | _aJameson, Mark J | |
| 773 | 0 |
_tThe Laryngoscope _gvol. 130 _gno. 6 _gp. 1470-1478 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/lary.28236 _zAvailable from publisher's website |
| 999 |
_c30025482 _d30025482 |
||